Frank H. Laukien (born 1960) is a German-American billionaire businessman and scientist, and president and CEO of Bruker since 2008.

[1] In 1984 he earned a bachelor's degree from Massachusetts Institute of Technology, and a PhD in chemical physics from Harvard University in 1988.

In 2017, he has been elected a senator of acatech, the German natural science and engineering academy.

[8][9] Laukien was the lead organizer of the Cancer & Evolution Symposium in Boston, US in October 2020.

[10] This led to the formation of the AACR Cancer Evolution Working Group, of which Laukien is joint co-chair with Charles Swanton.